A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
The purpose of the study is to see if stereotactic radiosurgery/SRS is an effective treatment for people with a new diagnosis of brain metastases from small cell lung cancer/SCLC.
Lung Cancer|Lung Cancer Metastatic|Brain Metastases|Brain Metastases, Adult|Small-cell Lung Cancer|Small Cell Lung Carcinoma
RADIATION: Stereotactic Radiosurgery|PROCEDURE: Cerebrospinal fluid collection
Overall survival, The primary endpoint of this study is the rate of overall survival at 6 months, with time measured from the start of SRS treatment. Participants will be censored at the date of last follow up or the last date the participant was known to be alive., 6 months
The purpose of the study is to see if stereotactic radiosurgery/SRS is an effective treatment for people with a new diagnosis of brain metastases from small cell lung cancer/SCLC.